✦ LIBER ✦

Paraneoplastic sensory neuropathy, demyelinating features, and response to immunotherapy

✍ Scribed by J.C. Antoine

Publisher: John Wiley and Sons
Year: 1998
Tongue: English
Weight: 94 KB
Volume: 21
Category: Article
ISSN: 0148-639X
DOI: 10.1002/(sici)1097-4598(199812)21:12<1811::aid-mus36>3.0.co;2-2

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paraneoplastic demyelinating neuropathy,

Paraneoplastic demyelinating neuropathy, subacute sensory neuropathy, and anti-hu antibodies: Clinicopathological study of an autopsy case

✍ Jean-Christophe Antoine; Jean-François Mosnier; Jérôme Honnorat; Philippe Conver 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 622 KB

A patient with anti-Hu antibodies, small-cell lung carcinoma, and autopsy-proven subacute sensory neuropathy had early slowing of motor and sensory conduction velocities. In the peripheral nerves, chronic demyelinating and remyelinating lesions with axonal degeneration were associated with an inflam

Response to therapy in demyelinating mot

Response to therapy in demyelinating motor neuropathy

✍ Lisa Markson; Donna Janzen; Vera Bril 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 85 KB 👁 1 views

We reviewed results of immunotherapy in patients with demyelinating motor neuropathy (DMN), and found that patients over 50 years of age at onset responded poorly, and younger patients responded variably to intervention. We suggest that patients with DMN be given a guarded prognosis, particularly if

Anti-Hu-associated paraneoplastic sensor

Anti-Hu-associated paraneoplastic sensory neuronopathy responding to early aggressive immunotherapy: Report of two cases and review of literature

✍ Shin J. Oh; Edward J. Dropcho; Gwen C. Claussen 📂 Article 📅 1997 🏛 John Wiley and Sons 🌐 English ⚖ 87 KB 👁 2 views

Anti-Hu-associated paraneoplastic sensory neuropathy (PSN) has been reported to be nonresponsive to immunotherapy or cancer therapy. We report 2 patients with anti-Hu-associated PSN who achieved sustained clinical improvement with early and aggressive immunotherapy 10-15 months before the diagnosis

Skin biopsy and quantitative sensory tes

Skin biopsy and quantitative sensory testing do not predict response to lidocaine patch in painful neuropathies

✍ David N. Herrmann; Valerie Pannoni; Richard L. Barbano; Janet Pennella-Vaughan; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 88 KB

Complete remission of paraneoplastic sen

Complete remission of paraneoplastic sensorimotor neuropathy: A case associated with small-cell lung cancer responsive to chemotherapy, plasma exchange, and radiotherapy

✍ Dr. David E. Weissman; Jerome L. Gottschall 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 338 KB 👁 1 views

A 61-year-old man was found to have small-cell lung cancer following a 1-year history of a progressive peripheral sensorimotor neuropathy . The neuropathy initially improved following chemotherapy, but subsequently progressed to the point of respiratory failure. Treatment with plasma exchange, addit